A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (Lenograstim) in patients undergoing chemotherapy for solid cancers and lyphoma.

A.m. Seymour, E. De Campos, N. Tharcher, Jacques De Greve, D. Cunningham, A. Howell, E. Tueni, D.g. Bron, W.p. Steward, We Berdel, A. Knuth, J. Lorenz, A.r. Timothy, A. Yver, M.a. Richards

Research output: Contribution to specialist/vulgarizing publicationArticleSpecialist

Original languageEnglish
Specialist publicationUnknown Journal
Publication statusPublished - 1995

Bibliographical note

European Journal of Cancer. 31:2157-2163, 1995

Cite this